Promising Early Results from Human Clinical Trial: New Alzheimer’s Treatment Targets Brain Resilience through P75 Neurotrophin Receptor
by Alzheimer’s disease, the leading cause of dementia, affects over 55 million individuals globally. Current treatment approaches primarily focus on addressing the buildup of amyloid beta …